HCA Holdings Inc (NYSE:HCA) – Jefferies Group reduced their FY2018 earnings per share estimates for HCA Holdings in a research note issued on Monday. Jefferies Group analyst B. Tanquilut now expects that the company will post earnings per share of $8.30 for the year, down from their prior forecast of $8.50.

A number of other research firms have also recently commented on HCA. Zacks Investment Research cut HCA Holdings from a “buy” rating to a “hold” rating in a report on Tuesday. Mizuho raised HCA Holdings from a “neutral” rating to a “buy” rating and set a $98.00 price target on the stock in a report on Monday, March 27th. Avondale Partners raised HCA Holdings from a “market perform” rating to an “outperform” rating and set a $96.00 price target on the stock in a report on Tuesday, January 17th. Evercore ISI boosted their price target on HCA Holdings to $88.00 and gave the stock a “buy” rating in a report on Tuesday, January 31st. Finally, Piper Jaffray Companies initiated coverage on HCA Holdings in a report on Wednesday, January 4th. They set an “overweight” rating and a $81.00 price objective on the stock. Five equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $90.22.

Earnings History and Estimates for HCA Holdings (NYSE:HCA)

TRADEMARK VIOLATION NOTICE: This story was reported by Daily Political and is the sole property of of Daily Political. If you are reading this story on another site, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The original version of this story can be read at http://www.dailypolitical.com/2017/04/18/fy2018-earnings-forecast-for-hca-holdings-inc-hca-issued-by-jefferies-group.html.

Shares of HCA Holdings (NYSE:HCA) traded down 0.51% during mid-day trading on Tuesday, reaching $85.21. The company had a trading volume of 2,295,431 shares. The stock has a market capitalization of $31.54 billion, a price-to-earnings ratio of 11.67 and a beta of 0.71. HCA Holdings has a 1-year low of $67.00 and a 1-year high of $91.03. The firm has a 50-day moving average price of $86.89 and a 200-day moving average price of $79.73.

HCA Holdings (NYSE:HCA) last announced its quarterly earnings results on Tuesday, January 31st. The company reported $1.89 EPS for the quarter, topping analysts’ consensus estimates of $1.78 by $0.11. HCA Holdings had a negative return on equity of 44.79% and a net margin of 6.84%. The company earned $10.64 billion during the quarter, compared to analyst estimates of $10.67 billion. During the same quarter last year, the firm posted $1.69 earnings per share. The firm’s revenue was up 3.8% on a year-over-year basis.

Institutional investors have recently added to or reduced their stakes in the stock. Howard Hughes Medical Institute acquired a new position in shares of HCA Holdings during the third quarter valued at approximately $124,000. Acrospire Investment Management LLC increased its position in shares of HCA Holdings by 5.3% in the third quarter. Acrospire Investment Management LLC now owns 2,000 shares of the company’s stock valued at $151,000 after buying an additional 100 shares during the period. HL Financial Services LLC acquired a new position in shares of HCA Holdings during the third quarter valued at approximately $201,000. Blenheim Capital Management BV acquired a new position in shares of HCA Holdings during the fourth quarter valued at approximately $207,000. Finally, Assenagon Asset Management S.A. acquired a new position in shares of HCA Holdings during the fourth quarter valued at approximately $217,000. 72.27% of the stock is currently owned by hedge funds and other institutional investors.

In other news, SVP Jana Joustra Davis sold 7,903 shares of the business’s stock in a transaction that occurred on Friday, February 3rd. The stock was sold at an average price of $82.49, for a total transaction of $651,918.47. Following the transaction, the senior vice president now owns 65,711 shares of the company’s stock, valued at approximately $5,420,500.39. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Ravi S. Chari sold 31,956 shares of the business’s stock in a transaction that occurred on Monday, March 27th. The shares were sold at an average price of $90.00, for a total value of $2,876,040.00. Following the transaction, the senior vice president now directly owns 7,754 shares in the company, valued at approximately $697,860. The disclosure for this sale can be found here. In the last three months, insiders have sold 271,394 shares of company stock worth $22,748,173. Corporate insiders own 3.10% of the company’s stock.

HCA Holdings Company Profile

HCA Holdings, Inc is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

5 Day Chart for NYSE:HCA

Receive News & Ratings for HCA Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.